AmerisourceBergen

AmerisourceBergen, now operating as Cencora, is a global pharmaceutical solutions organisation that supports access to healthcare for people and animals. Its work spans pharmaceutical manufacturer services, provider services, animal health solutions, and wholesale and specialty pharmaceutical distribution. The company employs more than 44,000 people and maintains over 1,300 locations worldwide, with operations centred in the United States and a global footprint.

The organisation reports annual revenue of more than $200 billion and ranks 11th on the Fortune 500. Through its distribution network it moves crucial medications to their destinations daily, and it serves 100 percent of U.S. hospitals. Provider services extend to hospitals, specialty pharmacies, hemophilia centres and home healthcare companies, while manufacturer support services partner with pharmaceutical innovators across the value chain to optimise market access to therapies.

Technical work is concentrated in pharmaceutical and wholesale distribution, specialty distribution, market access optimisation, supply chain and logistics, pharmaceutical manufacturer services, and animal health solutions. Sectors served include pharmaceuticals, life sciences, institutional healthcare, specialty pharmacy and animal health.

In August 2023 the company united its businesses and services under the single name Cencora. It describes its purpose as creating healthier futures and improving access to healthcare, with an emphasis on reliability, efficiency and security in delivering medications.